About this trial
The primary objective of this study was to evaluate the clinical feasibility, safety, and surgical characteristics of the EasyStars™ High Density Mapping Catheterin in patients with complex arrhythmias.
Eligibility criteria
Qualifiers
Clinical diagnosis: Ventricular tachycardia (VT)
Patients aged between 18 and 80 years;
Confirmed diagnosis of ventricular tachycardia (VT) via electrocardiogram (ECG) or 24-hour Holter monitoring;
The patient has experienced at least one episode of VT in the past 6 months and exhibits symptoms of sustained or paroxysmal ventricular tachycardia;
Disqualifiers
Uncontrolled heart failure (New York Heart Association functional class III-IV);
History of acute or progressive myocardial infarction;
Severe pulmonary, hepatic, or renal disease;
Valvular heart disease or congenital heart disease;
Trial design
Treatments tested in this trial
- EasyStars™ High Density Mapping Catheter
Treatment groups
Locations
Sponsors and collaborators
Shanghai MicroPort EP MedTech Co., Ltd.
Lead sponsor
Shanghai General Hospital, China
Collaborator